Volume 68, Issue 5, Pages (November 2015)

Slides:



Advertisements
Similar presentations
Cost of New Technologies in Prostate Cancer Treatment: Systematic Review of Costs and Cost Effectiveness of Robotic-assisted Laparoscopic Prostatectomy,
Advertisements

The PSA Era is not Over for Prostate Cancer
Volume 59, Issue 2, Pages (February 2011)
Volume 50, Issue 1, Pages (July 2006)
The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
Volume 58, Issue 4, Pages (October 2010)
Testosterone Therapy in Men With Prostate Cancer
Volume 56, Issue 6, Pages (December 2009)
Volume 61, Issue 6, Pages (June 2012)
Volume 67, Issue 1, Pages (January 2015)
Volume 73, Issue 2, Pages (February 2018)
Volume 54, Issue 4, Pages (October 2008)
Volume 74, Issue 2, Pages (August 2018)
Volume 60, Issue 5, Pages (November 2011)
Control of Prostate Cancer by Transrectal HIFU in 227 Patients
Volume 69, Issue 1, Pages (January 2016)
Volume 71, Issue 5, Pages (May 2017)
Who Benefits from Neoadjuvant or Adjuvant Hormone Therapy?
Prostate Cancer Epidemic in Sight?
Volume 61, Issue 1, Pages (January 2012)
Volume 59, Issue 6, Pages (June 2011)
The Importance of Transurethral Resection in Managing Patients With Urothelial Cancer in the Bladder: Proposal for a Transurethral Resection of Bladder.
Volume 68, Issue 5, Pages (November 2015)
Ute Ganswindt, Arnulf Stenzl, Michael Bamberg, Claus Belka 
Volume 60, Issue 5, Pages (November 2011)
Volume 70, Issue 4, Pages (October 2016)
Volume 70, Issue 3, Pages (September 2016)
Prostate Cancer Detection: A View of the Future
Volume 74, Issue 1, Pages (July 2018)
Ongoing Gleason Grade Migration in Localized Prostate Cancer and Implications for Use of Active Surveillance  Adam B. Weiner, Ruth Etzioni, Scott E. Eggener 
Volume 56, Issue 2, Pages (August 2009)
Volume 63, Issue 5, Pages (May 2013)
Volume 59, Issue 4, Pages (April 2011)
Volume 69, Issue 6, Pages (June 2016)
Volume 69, Issue 3, Pages (March 2016)
Volume 57, Issue 4, Pages e41-e42 (April 2010)
Active Surveillance for Prostate Cancer in a Real-life Cohort: Comparing Outcomes for PRIAS-eligible and PRIAS-ineligible Patients  Timo F.W. Soeterik,
Prostate Cancer Epidemic in Sight?
The PSA Era is not Over for Prostate Cancer
Volume 72, Issue 5, Pages (November 2017)
Volume 66, Issue 5, Pages (November 2014)
The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
Volume 68, Issue 6, Pages (December 2015)
Volume 61, Issue 6, Pages (June 2012)
Volume 66, Issue 2, Pages (August 2014)
Volume 58, Issue 1, Pages 1-7 (July 2010)
Volume 63, Issue 3, Pages (March 2013)
Long-term Cancer-specific Survival in Patients with High-risk, Non–muscle-invasive Bladder Cancer and Tumour Progression: A Systematic Review  Sven van.
Volume 71, Issue 1, Pages (January 2017)
The Inside-Out Transobturator Male Sling for the Surgical Treatment of Stress Urinary Incontinence After Radical Prostatectomy: Midterm Results of a Single-Center.
Volume 50, Issue 5, Pages (November 2006)
CyberKnife in the Treatment of Prostate Cancer: A Revolutionary System
Volume 71, Issue 5, Pages (May 2017)
The Importance of Testosterone Control in Prostate Cancer
The 20-Yr Outcome in Patients with Well- or Moderately Differentiated Clinically Localized Prostate Cancer Diagnosed in the Pre-PSA Era: The Prognostic.
Volume 72, Issue 2, Pages (August 2017)
Thomas Steuber, Matthew Frank O'Brien, Hans Lilja  European Urology 
Improving Outcomes in Prostate Cancer: Time to Tackle Bone Disorders
Improving Flexibility and Quality of Life for Your Patients: A Must?
Volume 53, Issue 5, Pages (May 2008)
Volume 68, Issue 5, Pages (November 2015)
Management of Prostate Cancer: Global Strategies
Edith Canby-Hagino, Javier Hernandez, Timothy C. Brand, Ian Thompson 
Volume 53, Issue 2, Pages (February 2008)
Treatment Options in Prostate Cancer Once Primary Therapy Fails
Bertrand Tombal, Richard Berges
Prostate Radiotherapy for Metastatic Hormone-sensitive Prostate Cancer: A STOPCAP Systematic Review and Meta-analysis  Sarah Burdett, Liselotte M. Boevé,
Ian W. Mills, Anna Crossland, Anup Patel, Henrikas Ramonas 
Volume 54, Issue 1, Pages (July 2008)
Volume 51, Issue 5, Pages (May 2007)
Presentation transcript:

Volume 68, Issue 5, Pages 891-898 (November 2015) Development of a Standardized Set of Patient-centered Outcomes for Advanced Prostate Cancer: An International Effort for a Unified Approach  Alicia K. Morgans, Annelotte C.M. van Bommel, Caleb Stowell, Janet L. Abrahm, Ethan Basch, Justin E. Bekelman, Donna L. Berry, Alberto Bossi, Ian D. Davis, Theo M. de Reijke, Louis J. Denis, Sue M. Evans, Neil E. Fleshner, Daniel J. George, Jim Kiefert, Daniel W. Lin, Andrew G. Matthew, Ray McDermott, Heather Payne, Ian A.G. Roos, Deborah Schrag, Thomas Steuber, Bertrand Tombal, Jean- Paul van Basten, Jacobus J.M. van der Hoeven, David F. Penson  European Urology  Volume 68, Issue 5, Pages 891-898 (November 2015) DOI: 10.1016/j.eururo.2015.06.007 Copyright © 2015 The Authors Terms and Conditions

Fig. 1 Selected sample timelines illustrating when particular outcomes and baseline factors should be collected for patients treated with different modalities. Example 1, one treatment given. Example 2, multiple treatments needed after specific events or disease progression. These timelines are intended to represent the outcome data collection points for possible treatment paths a patient could take, and do not advocate a particular treatment approach. Of note, a majority of baseline factors should be collected at the time of initiation of the advanced prostate cancer set, although several (eg, Gleason score, pathologic stage) are collected from information or treatment at the time of diagnosis. LPC=localized prostate cancer; PROMs=patient-reported outcome measurements. European Urology 2015 68, 891-898DOI: (10.1016/j.eururo.2015.06.007) Copyright © 2015 The Authors Terms and Conditions